Cronos Logo
CA22717L1013
A2DMQY
CRON

Cronos

A carregar cotações...

Previsão

O preço-alvo médio dos analistas é € 2,72 (+0,37%). A mediana é € 2,50 (-7,75%).

Comprar
  3
Manter
  9
Vender
  3

  • Cronos Group hits 52-week high after strong Q2 results

    The Cronos Group share rose to a 52-week high of $3.44, with a market capitalization of $1.25 billion and year-to-date performance of 25.86%. InvestingPro points to an overvaluation versus fair value. Cronos beat expectations in Q2 2026 with revenue of $53 million (expectation $44.73 million), adjusted EPS of $0.09 (expectation $0.01), gross profit of $28.5 million and adjusted EBITDA of $13.1 million; cash and investments amounted to $827 million, and $60 million in share buybacks were reported. » Mais em de.investing.com


  • Cronos shares rise after Q2 results significantly beat expectations

    Cronos reported Q2 EPS of $0.09 (consensus $0.01) and revenue of $53.0 million versus expected $44.73 million. The company reported record net revenue, gross profit and adjusted EBITDA, organic revenue growth of 51% and record sales in Israel, Canada and Germany. Cronos repurchased a total of 12.3 million shares in H1 2026. The strong company-specific metrics pushed the stock sharply higher in pre-market trading and brought it closer to its 52-week high. » Mais em de.investing.com


  • Cronos Group names ATB Capital Markets as broker for share buyback program

    Cronos Group has appointed ATB Capital Markets Corp. (ATB Cormark) as broker for share repurchases on the Toronto Stock Exchange and other Canadian trading systems, replacing Virtu Canada Corp. The company gave no details on the reasons, size or timing of the buyback program. Cronos has most recently pursued an aggressive buyback strategy, which coincided with a 49% share price increase last year; market capitalization is around USD 1.04 billion. » Mais em de.investing.com

Dados financeiros da empresa

No último trimestre, Cronos registou receitas de € 61,86 mi e um ganho líquido de € 28,11 mi
(EUR) junho de 2026
YoY
Receitas 61,86 mi 117,93%
Ganho bruto 24,93 mi 102,58%
Ganho líquido 28,11 mi 183,44%
EBITDA 31,63 mi 10.629,72%

Dados fundamentais

Métrica Valor
Capitalização bolsista
€ 1,02 bi
Número de ações
373,66 mi
Máximo/mínimo de 52 semanas
€ 3,11 - € 1,97
Dividendos Não
Beta
1,28
PER (PE Ratio)
16,89
PEG (PEG Ratio)
0,00
P/VC (PB Ratio)
1,11
P/V (PS Ratio)
6,62

Perfil da empresa

Die Cronos Group Inc. ist als Cannabinoid-Unternehmen tätig. Es produziert, vermarktet und vertreibt aus Hanf gewonnene Nahrungsergänzungsmittel und kosmetische Produkte über E-Commerce-, Einzelhandels- und Gaststättenpartnerkanäle unter den Marken Lord Jones und Happy Dance in den Vereinigten Staaten. Das Unternehmen befasst sich auch mit dem Anbau, der Herstellung und der Vermarktung von Cannabis und Cannabisprodukten für den medizinischen Markt und den Markt für den Gebrauch durch Erwachsene. Es verkauft Cannabis und Cannabisprodukte, darunter getrocknetes Cannabis, Pre-Rolls, Esswaren, Konzentrate und Cannabisextrakte über Großhandels- und Direktvertriebskanäle unter seiner Wellness-Plattform PEACE NATURALS und ist unter der Marke Spinach für den Gebrauch durch Erwachsene tätig. Das Unternehmen exportiert auch getrocknetes Cannabis und Cannabisöle nach Deutschland, Israel und Australien. Die Cronos Group Inc. wurde im Jahr 2012 gegründet und hat ihren Sitz in Toronto, Kanada.

Nome
Cronos
CEO
Michael Ryan Gorenstein
Sede Stayner, on
Canadá
Site
Setor
Cuidados de saúde
Indústria
Cuidados de saúde: prestadores e serviços
Entrada em bolsa
27/02/2018
Colaboradores 610

Símbolos de ticker

Bolsa Símbolo
NASDAQ
CRON
Toronto Stock Exchange
CRON.TO
Frankfurt
7CI.F
Düsseldorf
7CI.DU
München
7CI.MU
🍪

Parqet  utiliza cookies. Saber mais